Sophia Genetics (NASDAQ:SOPH) Stock, Quote.Headers.trade-ideas

Sophia Genetics

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Movers

News

Intraday Update

Markets

Trading Ideas

ASTI

ASTS

AWIN

BNAI

BNZI

CAVA

CHWY

CNEY

CRKN

FFIE

GENE

GYRE

HLTH

IKNA

IMVT

Kintara Therapeutics, Inc. - Common Stock

KTRA

LUCY

MBIO

MRVI

NEON

ONFO

OOMA

POAI

RSLS

SCPX

SMLR

SOBR

SOPH

SRDX

STSS

SYTA

TANH

TITN

TOST

VERU

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

MOMO

NABL

Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie &amp; Fitch And Other Big Stocks Moving Higher On Wednesday

Penny Stocks

Small Cap

AFMD

AISP

APEI

BASE

BIAF

BYSI

CERS

CETX

CMAX

CRWD

CXDO

DADA

DAVE

ENCP

FULC

GNPX

GRFS

HIPO

HSCS

IFBD

INFN

JAGX

LTRN

LYFT

MEDS

MNTS

MSTR

NEPT

NKGN

OCEA

PHUN

ROOT

RVSN

SBFM

SGHC

TTEC

UNFI

VINC

XRTX

Shares of  United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Sophia Genetics SA

Cantor Fitzgerald analyst Deepak Mathivanan reiterates MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Overweight and maintains $2530 price target.

Price Target

Reiteration

Analyst Ratings

MELI

Cantor Fitzgerald Reiterates Overweight on MercadoLibre, Maintains $2530 Price Target

Reliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RS#NYSE">RS</a>) has outperformed the market over the past 20 years by 5.72% on an annualized basis producing an average annual return of 14.2%. Currently, Reliance has a market capitalization of $15.46 billion. 
Buying $100 In RS: If an investor had bought $100 of RS stock 20 years ago, it would be worth $1,451.91 today based on a price of $281.08 for RS at the time of writing.
<h3>Reliance's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727101816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,500 Today

American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) has outperformed the market over the past 20 years by 6.13% on an annualized basis producing an average annual return of 14.61%. Currently, American Tower has a market capitalization of $109.61 billion. 
Buying $100 In AMT: If an investor had bought $100 of AMT stock 20 years ago, it would be worth $1,568.65 today based on a price of $234.67 for AMT at the time of writing.
<h3>American Tower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727101811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning American Tower Stock In The Last 20 Years

Macro Economic Events

Global

Economics

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

U.S. State Dept Spokesperson Says Israeli Military Operation That Shut Down Al Jazaeera's Ramallah Office Is Concerning; Israel's Action Is Inconsistent With U.S. Support For Freedom Of The Press In The West Bank And All Over The World

WIIM

SKYE

Skye Bioscience shares are trading higher in possible sympathy with Novo Nordisk which announced Phase 2a topline data with Monlunabant and reiterated confidence in its Nimacimab clinical development plan.

<a href="https://www.chicagofed.org/publications/speeches/2024/sept-23-national-association-state-treasurers" title="https://www.chicagofed.org/publications/speeches/2024/sept-23-national-association-state-treasurers">https://www.chicagofed.org/publications/speeches/2024/sept-23-national-association-state-treasurers</a>

Federal Reserve

Fed's Goolsbee Says 0.7% Increase In Unemployment Over A Year Is Usually A Warning Sign Of Recession; Directionally Unemployment Is Rising, But Level Is Still Low; Rise In Delinquencies Is Also A Warning Sign; GDP Growth, Consumer Spending, Wage Growth Has Been Strong; It's A Little Bit Of A 'Cautionary' Period

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Neutral and maintains $13 price target.

Cantor Fitzgerald Reiterates Neutral on Lyft, Maintains $13 Price Target

Billionaire investors and Berkshire Hathaway executives Warren Buffett and Charlie Munger will forever be known for their annual shareholders meetings that often included advice on investing <a href="https://www.benzinga.com/general/education/24/07/39716106/common-sense-is-actually-uncommon-charlie-munger-said-standard-human-condition-is-ignorance-and">and life lessons.</a>
A question at the 2011 annual shareholders meeting highlighted advice on how rich people should handle their children.
What Happened: At the 2011 annual <a href="https://www.benzinga.com/topic/berkshire-hathaway-annual-meeting">Berkshire Hathaway shareholders meeting</a>, Buffett and Munger took turns answering a unique question about parenting from an audience member.
The question was how to get rich people&#8217;s kids to stay incentivized.
"How would you incentivize him or her to compete against the hungry and highly motivated kids from emerging markets like China, Brazil, Russia, or India?" the audience member asked.
Buffett, who has three children, attempted to answer the question first by sharing his perspective on parenting while being wealthy.
"If you are very rich and you bring up your kids to think that they are more important in society or that they have some special privilege… that's just a terrible mistake," Buffett <a href="https://www.youtube.com/watch?v=cdPiOWtCrYk">said</a>.
Buffett later said he was rich when his kids got into high school and college.
"I certainly didn't want to give them the idea that they were special just because their parents were rich."
The billionaire, who is also known as the Oracle of Omaha, said you don't want to get a bad result or have children who don't have any incentive because their parents are rich. He noted that while it&#8217;s crucial to avoid stifling ambition, it&#8217;s equally important not to create incentives for them to compete with their parents&#8217; successes.
"I don't think that makes sense."
Buffett added that if you&#8217;re wealthy and your children lack motivation, the responsibility ultimately falls on the parents.
He emphasized that it&#8217;s crucial for children of wealthy parents to be raised with the understanding that they shouldn&#8217;t rely on others to do the work for them, as this could lead to poor outcomes.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent092024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Charlie Munger's Advice: When discussing entitlement, Buffett remarked that none of Munger&#8217;s children seemed to have that mindset. Munger, the longtime Berkshire Hathaway vice chairman, who <a href="https://www.benzinga.com/news/23/11/35989969/charlie-munger-buffetts-trusted-partner-dies-at-99">passed away in November 2023</a> at 99, said it's important to have the right expectations when it comes to parenting while being wealthy.
"I don't think you can raise children, an affluent family, and have them love working 60 hours a week," Munger said. "That's not going to work."
&#8220;To some extent, you are destroying certain kinds of incentives,&#8221; he added.
Perhaps, Munger's ultimate parenting advice that applies to being rich and raising kids and maybe life itself is something many will find familiar.
"My advice to you is lose your fight as gracefully as you can."
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent092024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Education

Success Stories

Charlie Munger Was Asked How To Avoid Spoiling Children When You're Rich — Warren Buffett's Longtime Partner Gave His Realistic Advice: 'Lose Your Fight As Gracefully As You Can'

Chevron Says Nonessential Personnel Being Transported From Gulf Of Mexico Facilities, No Effect To Production At These Platforms Due To Tropical Weather; Storm Preparedness Procedures Being Followed At Onshore Facilities

AESI

FANG

GEVO

LBRT

SHEL

Shares of oil companies are trading higher amid anticipation for potential conflict escalations between Israel-Lebanon and the broader region.

- 2024 Bank of America European Autos and Future Car Virtual Conference&nbsp;&nbsp;&nbsp;&nbsp;

Guidance

STLA

Stellantis CFO Says Moving To Have 80% Of Supply Coming From Best Cost Countries From 2028

Citigroup analyst Ronald Josey maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $580 to $645.

Citigroup Maintains Buy on Meta Platforms, Raises Price Target to $645

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Neutral and maintains $190 price target.

GOOGL

Cantor Fitzgerald Reiterates Neutral on Alphabet, Maintains $190 Price Target

Truist Securities analyst David Macdonald maintains RadNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>) with a Buy and raises the price target from $70 to $80.

RDNT

Truist Securities Maintains Buy on RadNet, Raises Price Target to $80

Fed's Goolsbee Says Golden Path Is In The Books, Inflation Came Down Without A Recession Last Year

Truist Securities analyst Scot Ciccarelli maintains CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) with a Hold and raises the price target from $70 to $75.

Truist Securities Maintains Hold on CarMax, Raises Price Target to $75

Trump Media & Technology shares are trading lower possibly amid the expiration of the lockup period that prevents large shareholders, such as Donald Trump, from selling stocks. Also, Donald Trump rejected a second debate with Vice President Harris.

Truist Securities analyst William Stein downgrades Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) from Buy to Hold and lowers the price target from $89 to $80.

Downgrades

MCHP

Truist Securities Downgrades Microchip Technology to Hold, Lowers Price Target to $80

Israeli Military Says Warning Sirens Sound In The Shomron Area Of The Northern West Bank

Oil is trading higher amid Israel-Hezbollah tensions in Lebanon, which has caused supply uncertainty.

In a report released on June 21, Conor McNamara from RBC Capital maintained a Buy rating on SOPHiA GENETICS (SOPH – Research Report), with a price ...

RBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)

SOPHiA GENETICS (SOPH) has released an update. SOPHiA GENETICS SA, with its base in Rolle, Canton of Vaud, Switzerland, focuses on the management a...

SOPHiA GENETICS: Versatile Corporate Structure and Global Ambitions

SOPHiA Genetics reports Q2 results

SOPHiA GENETICS (SOPH) has released an update. SOPHiA GENETICS SA has reported its unaudited interim condensed consolidated financial results, indi...

SOPHiA GENETICS Reports Mid-Year Financials

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sophia Genetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/soph-stock-quote/">SOPH</a>) just reported results for the second quarter of 2024.<ul><li>Sophia Genetics reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -28 cents.</li><li>The company reported revenue of $15.81 million.</li><li>This was 9.15% worse than the analyst estimate for revenue of $17.40 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/soph-stock-earnings-sophia-genetics-for-q2-of-2024/">SOPH Stock Earnings: Sophia Genetics Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SOPH Stock Earnings: Sophia Genetics Beats EPS, Misses Revenue for Q2 2024

SOPHiA GENETICS SA (SOPH) Q2 2024 Earnings Call Transcript

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on SOPHiA GENETICS (SOPH – Research Report). The company's shares ...

TD Cowen Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)

Morgan Stanley analyst Tejas Savant downgraded the rating on SOPHiA GENETICS (SOPH – Research Report) to a Hold today, setting a price target of $5...

Hold Rating on SOPHiA GENETICS Amidst Q2 Revenue Shortfall and Balanced Risk/Reward Outlook

Tracking Al Gore's Generation Investment Management Portfolio - Q2 2024 Update

TD Cowen analyst Daniel Brennan maintained a Buy rating on SOPHiA GENETICS (SOPH – Research Report) today. The company's shares closed yesterday at...

SOPHiA GENETICS (SOPH) Gets a Buy from TD Cowen

AMZN

CBRE

CLVT

FRSH

HSIC

MSFT

NTNX

RELY

SCHW

TRMB

TSMWF

TWLO

TYGO

WDAY

XRAY

Press Releases

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

Earnings

SOPHiA GENETICS Reports Second Quarter 2024 Results

SOPHiA DDM™ Platform Certified Under IVDR

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Contracts

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Sophia Genetics

Sophia Genetics (SOPH) Forecast

Sophia Genetics (NASDAQ:SOPH) Stock, Quote.Headers.trade-ideas